Upregulated lncRNA PRNT promotes progression and oxaliplatin resistance of colorectal cancer cells by regulating HIPK2 transcription

doi:10.4251/wjgo.v16.i4.1564

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1471)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series, Tables (1-1) series.

Item

Count

PDF

HTML

757

Figures (1-9)

147

Tables (1-1)

136

Sum=1087

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

271

Sum=329

Apr 15, 2024 (publication date) through Nov 13, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1564-1577
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1564

Full Size Figure Download Figure

Figure 7 The expression of homeodomain interacting protein kinase 2 and zinc finger protein 184 in prion protein testis specific overexpression and knockdown HCT116/L cells (A) and LoVo/L cells (B) by westernblot. ^cP < 0.001. PRNT: Prion protein testis specific; NC: Negative control; ZNF184: Zinc finger protein 184; HIPK2: Homeodomain interacting protein kinase 2.

Citation: Li SN, Yang S, Wang HQ, Hui TL, Cheng M, Zhang X, Li BK, Wang GY. Upregulated lncRNA PRNT promotes progression and oxaliplatin resistance of colorectal cancer cells by regulating HIPK2 transcription. World J Gastrointest Oncol 2024; 16(4): 1564-1577
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1564.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1564